Ambey Laboratories IPO Logo

Ambey Laboratories IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Jul 04 to Jul 08 2024
Price Band ₹65 - 68
Current GMP ₹85(25.0%)
Subscription 173.18 times

IPO Details

IPO Date
July 4, 2024 to July 8, 2024
Listing Date
Thursday, July 11, 2024
Face Value
₹10 per share
Price Band
₹65 to ₹68 per share
Lot Size
2000 Shares
Total Issue Size
6,570,000 shares (aggregating up to ₹44.68 Cr)
Fresh Issue
6,258,000 shares (aggregating up to ₹42.55 Cr)
Offer for Sale
312,000 shares of ₹10 (aggregating up to ₹2.12 Cr)
Issue Type
Book Built Issue IPO
Listing At
NSE SME
Share holding pre issue
18,688,819
Share holding post issue
25,258,819
Market Maker portion
330,000 shares Nikunj Stock Brokers

IPO Subscription Details

Anchor Investors
1
Market Maker
1
Qualified Institutions
61.90
Non-Institutional Buyers***
324.22
Retail Investors
195.06
Total **
173.18

Day Wise Sub

DayDay 1 Jul 4, 2024
QIB0.41
NII*19.86
Retail28.80
Total18.66
DayDay 2 Jul 5, 2024
QIB0.41
NII*50.39
Retail64.90
Total42.75
DayDay 3 Jul 8, 2024
QIB61.90
NII*324.22
Retail195.06
Total173.18

Day Wise GMP

Date10-07-2024
Price68.00
GMP28(41.18%)
Estimate List Price96
Date09-07-2024
Price68.00
GMP35(51.47%)
Estimate List Price103
Date08-07-2024
Price68.00
GMP35(51.47%)
Estimate List Price103
Date07-07-2024
Price68.00
GMP46(67.65%)
Estimate List Price114
Date06-07-2024
Price68.00
GMP46(67.65%)
Estimate List Price114
Date05-07-2024
Price68.00
GMP44(64.71%)
Estimate List Price112
Date04-07-2024
Price68.00
GMP40(58.82%)
Estimate List Price108
Date03-07-2024
Price68.00
GMP33(48.53%)
Estimate List Price101
Date02-07-2024
Price68.00
GMP27(39.71%)
Estimate List Price95
Date01-07-2024
Price68.00
GMP22(32.35%)
Estimate List Price90
Date30-06-2024
Price68.00
GMP0(0.0%)
Estimate List Price68
Date29-06-2024
Price68.00
GMP0(0.0%)
Estimate List Price68
Date28-06-2024
Price68.00
GMP0(0.0%)
Estimate List Price68

IPO Important Dates

IPO Open Date
Thursday, July 4, 2024
IPO Close Date
Monday, July 8, 2024
Basis of Allotment
Tuesday, July 9, 2024
Initiation of Refunds
Wednesday, July 10, 2024
Credit of Shares to Demat
Wednesday, July 10, 2024
Listing Date
Thursday, July 11, 2024
Cut-off time for UPI mandate confirmation
5 PM on July 8, 2024

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares2000
Amount₹136,000
ApplicationRetail (Max)
Lots1
Shares2000
Amount₹136,000
ApplicationHNI (Min)
Lots2
Shares4,000
Amount₹272,000

Financial Information

Period EndedPeriod Ended
31 Jan 202431 Jan 2024
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Jan 20248,620.84
31 Mar 20235,761.85
31 Mar 20225,592.94
Period EndedRevenue
31 Jan 202410,043.69
31 Mar 202310,743.47
31 Mar 20228,511.19
Period EndedProfit After Tax
31 Jan 2024607.73
31 Mar 2023456.93
31 Mar 2022357.47
Period EndedNet Worth
31 Jan 20243,431.34
31 Mar 20232,363.60
31 Mar 20221,906.67
Period EndedReserves and Surplus
31 Jan 20241,562.46
31 Mar 2023588.66
31 Mar 2022131.73
Period EndedTotal Borrowing
31 Jan 20242,005.44
31 Mar 20231,365.22
31 Mar 20221,804.86

Key Performance Indicator

ROE
20.80%
ROCE
13.14%
Debt/Equity
0.58
RoNW
20.80%
P/BV
3.58
PAT Margin (%)
6.01
EPS (Rs)
2.44

IPO Reservation

Anchor Investor Shares Offered
1,872,000 (29.98%)
Market Maker Shares Offered
330,000 (5.29%)
QIB Shares Offered
1,252,000 (20.05%)
NII (HNI) Shares Offered
606,001 (9.71%)
Retail Shares Offered
2,184,000 (34.98%)
Total Shares Offered
6,244,001 (100%)

Information about company

Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades. The company manufactures and supplies 2,4-D base chemicals. The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation. The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd: 2,4-D Acid 98% TC 2,4-D Sodium 95% SP 2,4-D Amine 866 | 720 | 480g/l SL 2,4-D Ethyl Hexyl Ester 96% TC 2,4-D Ethyl Ester 96% TC Chlorpyriphos 97%TC / 20%EC / 50%EC Thiamethoxam 96%TC / 25%WG / 75%SG Pretilachlor 95%TC / 50%EC / 37%EW Metribuzin 97%TC / 70%WS Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC Metalaxyl 98%TC / 35%WS  As of October 31, 2023 the company employs 220 people in various departments.

Objectives of IPO

The company intends to utilize the Net Proceeds for the following objects: To meet Working Capital Requirements General corporate purposes Issue related expenses

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App